The RegenBio Summit is a gathering of thought leaders and experts at the forefront of regenerative medicine, biomanufacturing, and translational research. This dynamic event aims to accelerate the transformation of next-generation biotherapeutics. The focus extends across diverse medical specialties, including orthopedics, oncology, cardiovascular medicine, neurosciences, and transplantation, among other medical and surgical specialties. This summit focuses on advancing pioneering regenerative biotherapies, setting the stage for a new era of medical and surgical possibilities.
As part of the RegenBio Summit: Transforming Next-Gen Biotherapeutics 2024, trainees are invited to submit an abstract for presentation of original research dedicated to the field of regenerative medicine. Projects can be clinical or laboratory based. Abstracts should be 1,750 words or less.
Apply Here – Deadline to submit is September 6, 2024 at 11:59 CST
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
